MyFinsight
Home
Blog
About
Contact
Download
Download image
Attributable to
non-controlling interests
-$39,730K
(46.93%↑ Y/Y)
Net loss
attributable to common...
-$1,882K
(96.63%↑ Y/Y)
Net income (loss)
attributable to fortress
$6,815K
(114.82%↑ Y/Y)
Net loss
-$32,915K
(72.76%↑ Y/Y)
Income tax expense
(benefit)
-$620K
(-298.72%↓ Y/Y)
Gain from
deconsolidation of subsidiary
$27,127K
Other income
$17,578K
(1233.69%↑ Y/Y)
Avenue Therapeutics
Inc
$1,404K
(697.73%↑ Y/Y)
Journey
$619K
(914.75%↑ Y/Y)
Interest income
$2,485K
(-7.38%↓ Y/Y)
Preferred a dividends
declared and paid and/or...
$8,697K
(-12.09%↓ Y/Y)
Loss before income
tax expense
-$33,535K
(72.18%↑ Y/Y)
Total other income
(expense)
$36,686K
(460.94%↑ Y/Y)
Product revenue, net
$61,239K
(11.07%↑ Y/Y)
Other revenue
$2,023K
(102.30%↑ Y/Y)
Interest expense and
financing fee
$10,106K
(-25.29%↓ Y/Y)
Loss on common stock
warrant liabilities
-$398K
(37.62%↑ Y/Y)
Loss from operations
-$70,221K
(36.38%↑ Y/Y)
Net revenue
$63,262K
(9.69%↑ Y/Y)
Total operating
expenses
$133,483K
(-20.57%↓ Y/Y)
Selling, general and
administrative
$96,400K
(9.88%↑ Y/Y)
Cost of goods -
(excluding amortization of...
$20,924K
(0.22%↑ Y/Y)
Research and development
$11,901K
(-78.98%↓ Y/Y)
Amortization of acquired
intangible assets
$4,258K
(24.36%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)